NEPH Stock Analysis: Buy, Sell, or Hold?
NEPH - Nephros Inc.
$3.35
0.05 (1.52%)
▲
5d:
+5.02%
30d:
-3.46%
90d:
+9.84%
BUY
HIGH Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When NEPH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: NEPH shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: NEPH shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: NEPH is currently trading at $3.35, which is considered slightly low relative to its 30-day fair value range of $3.25 to $3.66. From a valuation perspective, the stock is trading at a premium (Forward PE: 33.5) compared to its historical average (28.7). At these levels, the market is pricing in 5.3% annual earnings growth.
Technical Outlook: Technically, NEPH is in a downtrend. The price is currently testing key support at $3.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.00 (+109.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, NEPH is in a downtrend. The price is currently testing key support at $3.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.00 (+109.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.25 -
$3.66
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 109.0% below Wall St target ($7.00)
- BULLISH: Expecting earnings turnaround to 5.3% growth with 6.9% revenue growth
Trading Range Analysis
30-Day Trading Range
$3.25 -
$3.66
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.25
Resistance Level
$3.82
Current Trend
Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
33.50
Wall Street Target
$7.00
(+109.0%)
Revenue Growth (YoY)
6.9%
Earnings Growth (YoY)
-80.0%
Profit Margin
4.1%
Valuation Premium vs History
+5.3% premium
PE vs Historical
33.5 vs 28.7
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.3%
(market-implied from PE analysis)
1-Year Target
$3.53
(+5%)
2-Year Target
$3.71
(+11%)
3-Year Target
$3.91
(+17%)
3-Yr Target (if PE normalizes)
(PE: 34→29)
PE COMPRESSION
$3.35
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 33.5, Growth: 122.2%)
$11.31
(+238%)
Base:
(SPY PE: 21.8, Growth: 122.2%)
$7.35
(+119%)
Bear:
(PE: 18.5, Growth: 122.2%)
$6.25
(+87%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (47x PE), but valuation improves significantly next year (34x PE) as earnings recover.
Trailing PE: 47.14 | Current EPS (TTM): $0.07
Bull Case
$5.19
(+55%)
Analyst growth 42.9%, PE expands to 51.9
Base Case
$4.71
(+41%)
Market implied 42.9%, PE stable at 47.1
Bear Case
$2.24
(-33%)
Severe decline -20.0%, PE contracts to 40.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 24, 2026 11:12 PM ET
Data refreshes hourly during market hours. Next update: 12:12 AM
Data refreshes hourly during market hours. Next update: 12:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NEPH showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$565 | 59 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$88 | 60 BUY |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$359 | 69 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$262 | 67 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$176 | 55 HOLD |
